October 21, 2014: Foster City, Calif.-based Gilead Sciences announced today it has broken ground on another R&D lab in Edmonton, Alberta’s Eco Industrial Park. This facility will be adjacent to existing facilities, including a laboratory that is nearing completion.
October 20, 2014: NewLink Genetics Corp. is having a banner month. Thel company announced today that it has inked a deal potentially worth $1 billion with Genentech, a member of the Roche Group, for the development of NLG919, NewLink's IDO pathway inhibitor.
October 20, 2014: Allergan Inc., maker of Botox, filed on Friday with the California Employment Development Department, indicating they will lay off 40 employees in Carlsbad, Calif.
October 21, 2014: Here's BioSpace's guide to who's working on therapeutics or vaccines for Ebola and how those pipelines are progressing. Companies that are not included in the list but are also developing Ebola treatments are encouraged to contact BioSpace.